Healthcare Realty Trust Incorporated
HRNYSECIK 1360604Real Estate / REITsfiscal year ends December66 quarters since 2010
Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q1 FY2026ended Mar 31, 2026filed May 1, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025 | Q1 FY2025ended Mar 31, 2025filed May 1, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 19, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 287 | 282 | 279 | 286 | 298 | 298 | 299 | 310 | −3.7% |
| Cost of revenue | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 12 | 14 | 17 | 14 | 22 | 23 | 14 | 34 | −42.9% |
| Operating income | — | — | — | — | — | — | — | — | — |
| Other income (expense) | (58) | (83) | (32) | (19) | (83) | (176) | (64) | (107) | +30.4% |
| Pretax income | — | — | — | — | — | — | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — |
| Net income | (16) | (44) | 0 | 14 | (58) | (158) | (45) | (107) | +72.7% |
| Diluted EPS ($) | (0.05) | (0.13) | 0.00 | — | (0.17) | (0.45) | (0.13) | — | +70.6% |
| Diluted shares (millions) | 341 | 342 | 347 | — | 350 | 350 | 350 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q1 FY2026ended Mar 31, 2026filed May 1, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025 | Q1 FY2025ended Mar 31, 2025filed May 1, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 19, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 17 | 19 | 26 | 26 | 43 | 26 | 26 | 69 | −59.6% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — |
| Total assets | 8,960 | 9,001 | 9,148 | 9,211 | 9,860 | 10,236 | 10,496 | 10,651 | −9.1% |
| Total current liabilities | — | — | — | — | — | — | — | — | — |
| Long-term debt | 4,249 | 4,167 | 4,104 | 3,911 | 4,486 | 4,694 | 4,733 | 4,663 | −5.3% |
| Total debt | 4,249 | 4,167 | 4,104 | 3,911 | 4,486 | 4,694 | 4,733 | 4,663 | −5.3% |
| Total liabilities | 4,825 | 4,728 | 4,651 | 4,534 | 5,115 | 5,354 | 5,349 | 5,345 | −5.7% |
| Stockholders’ equity | 4,080 | 4,217 | 4,439 | 4,617 | 4,683 | 4,817 | 5,078 | 5,235 | −12.9% |
| Shares outstanding (millions) | 339 | 343 | 347 | 349 | 352 | 352 | 351 | 351 | — |
Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q1 FY2026ended Mar 31, 2026filed May 1, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025 | Q1 FY2025ended Mar 31, 2025filed May 1, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 19, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 122 | 142 | 53 | 132 | 114 | 163 | 48 | 138 | +7.5% |
| Capital expenditures | — | — | — | — | — | — | — | — | — |
| Free cash flow (CFO − capex) | — | — | — | — | — | — | — | — | — |
| Depreciation and amortization | 128 | 128 | 129 | withheld | withheld | withheld | withheld | 160 | — |
| Share repurchases | 0 | 1 | 2 | 0 | 3 | 0 | 0 | 9 | −98.5% |
| Dividends paid | 82 | 82 | 84 | 84 | 85 | 109 | 109 | 110 | −3.0% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 13, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 13, 2026 | FY2024ended Dec 31, 2024filed Feb 19, 2025 | FY2023ended Dec 31, 2023filed Feb 16, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Feb 24, 2021 | FY2019ended Dec 31, 2019filed Feb 18, 2020 | FY2018ended Dec 31, 2018filed Feb 19, 2019 | FY2017ended Dec 31, 2017filed Feb 20, 2018 | FY2016ended Dec 31, 2016filed Feb 21, 2017 | FY2015ended Dec 31, 2015filed Feb 22, 2016 | FY2014ended Dec 31, 2014filed Feb 23, 2015 | FY2013ended Dec 31, 2013filed Feb 25, 2014 | FY2012ended Dec 31, 2012filed Mar 1, 2013 | FY2011ended Dec 31, 2011filed Mar 27, 2012 | FY2010ended Dec 31, 2010filed Aug 15, 2011 | FY2009ended Dec 31, 2009filed Aug 15, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,181 | 1,268 | 1,344 | 933 | 535 | 500 | 692 | 696 | 614 | 461 | 404 | 372 | 322 | 300 | 272 | 203 | 129 |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 73 | 83 | 58 | 53 | 34 | 31 | 41 | 35 | 33 | 29 | 26 | 25 | 24 | 22 | 21 | 16 | 12 |
| Operating income | — | — | — | — | — | — | — | — | 124 | 102 | 94 | 83 | 66 | 30 | 46 | 22 | (1) |
| Other income (expense) | (342) | (697) | (336) | 65 | (15) | (7) | 1 | 0 | 0 | 0 | (1) | 0 | 0 | 0 | 0 | — | — |
| Pretax income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | (246) | (654) | (278) | 41 | 67 | 72 | 30 | 213 | 64 | 46 | 33 | 45 | 24 | (24) | 6 | (8) | (25) |
| Diluted EPS ($) | (0.71) | (1.81) | (0.74) | 0.15 | 0.45 | 0.52 | 0.14 | 1.02 | 0.34 | 0.33 | 0.26 | 0.37 | 0.21 | (0.22) | 0.02 | (0.05) | (0.22) |
| Diluted shares (millions) | 350 | 366 | 379 | 254 | 143 | 134 | 210 | 210 | 185 | 140 | 128 | 121 | 115 | 111 | 224 | 166 | 113 |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 13, 2026 | FY2024ended Dec 31, 2024filed Feb 19, 2025 | FY2023ended Dec 31, 2023filed Feb 16, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Feb 24, 2021 | FY2019ended Dec 31, 2019filed Feb 18, 2020 | FY2018ended Dec 31, 2018filed Feb 19, 2019 | FY2017ended Dec 31, 2017filed Feb 20, 2018 | FY2016ended Dec 31, 2016filed Feb 21, 2017 | FY2015ended Dec 31, 2015filed Feb 22, 2016 | FY2014ended Dec 31, 2014filed Feb 23, 2015 | FY2013ended Dec 31, 2013filed Feb 25, 2014 | FY2012ended Dec 31, 2012filed Mar 1, 2013 | FY2011ended Dec 31, 2011filed Mar 27, 2012 | FY2010ended Dec 31, 2010filed Aug 15, 2011 | FY2009ended Dec 31, 2009filed Aug 15, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 26 | 69 | 26 | 61 | 13 | 115 | 33 | 126 | 100 | 11 | 13 | 10 | 18 | 16 | 69 | 29 | 219 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | 9,211 | 10,651 | 12,637 | 13,850 | 4,259 | 6,791 | 6,639 | 6,188 | 6,450 | 3,748 | 3,172 | 3,031 | 2,752 | 2,414 | 2,292 | 2,272 | — |
| Total current liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | 3,911 | 4,663 | 4,995 | 5,352 | 1,801 | 3,027 | 2,750 | 2,541 | 2,781 | 1,769 | 1,591 | 1,402 | 1,214 | 1,037 | 639 | — | — |
| Total debt | 3,911 | 4,663 | 4,995 | 5,352 | 1,801 | 3,027 | 2,750 | 2,541 | 2,781 | 1,769 | 1,591 | 1,402 | 1,214 | 1,037 | 639 | — | — |
| Total liabilities | 4,534 | 5,345 | 5,714 | 6,168 | 2,074 | 3,556 | 3,208 | 2,847 | 3,079 | 1,963 | 1,761 | 1,551 | 1,349 | 1,146 | 721 | 781 | — |
| Stockholders’ equity | 4,617 | 5,235 | 6,823 | 7,571 | 2,185 | 1,948 | 3,358 | 3,256 | 3,279 | 1,687 | 1,379 | 1,447 | 1,387 | 1,254 | 1,567 | 1,487 | 1,071 |
| Shares outstanding (millions) | 349 | 351 | 381 | 381 | 229 | 219 | 217 | 205 | 205 | 142 | 131 | 125 | 237 | — | 230 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 13, 2026 | FY2024ended Dec 31, 2024filed Feb 19, 2025 | FY2023ended Dec 31, 2023filed Feb 16, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Feb 24, 2021 | FY2019ended Dec 31, 2019filed Feb 18, 2020 | FY2018ended Dec 31, 2018filed Feb 19, 2019 | FY2017ended Dec 31, 2017filed Feb 20, 2018 | FY2016ended Dec 31, 2016filed Feb 21, 2017 | FY2015ended Dec 31, 2015filed Feb 22, 2016 | FY2014ended Dec 31, 2014filed Feb 23, 2015 | FY2013ended Dec 31, 2013filed Feb 25, 2014 | FY2012ended Dec 31, 2012filed Mar 1, 2013 | FY2011ended Dec 31, 2011filed Mar 27, 2012 | FY2010ended Dec 31, 2010filed Aug 15, 2011 | FY2009ended Dec 31, 2009filed Aug 15, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 457 | 502 | 500 | 273 | 233 | 470 | 340 | 337 | 308 | 204 | 191 | 168 | 148 | 117 | 112 | 59 | 22 |
| Capital expenditures | — | — | — | — | 97 | 75 | 92 | 78 | 65 | 43 | 29 | 29 | 25 | 23 | 16 | 15 | 9 |
| Free cash flow (CFO − capex) | — | — | — | — | 135 | 395 | 249 | 260 | 243 | 161 | 162 | 139 | 122 | 94 | 96 | 44 | 13 |
| Depreciation and amortization | 564 | 675 | 731 | 453 | 203 | 190 | 290 | 280 | 245 | 177 | 154 | 140 | 122 | 116 | 107 | 79 | 54 |
| Share repurchases | 4 | 9 | 2 | 3 | 4 | 1 | 12 | 70 | 3 | 3 | 2 | 1 | 1 | 183 | 38 | 52 | 16 |
| Dividends paid | 387 | 458 | 472 | 284 | 175 | 163 | 256 | 253 | 207 | 159 | 146 | 137 | 129 | 93 | 85 | 60 | 40 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Hull Robert E | EVP and COO | open-market sale | 21,000 | $19.11 | $401K | 276,338 | Sep 9, 2026 |
| Jun 23, 2026 | Callaway Amanda L | SVP & Chief Accounting Officer | open-market sale | 25,767 | $20.37 | $525K | 109,954 | Jun 23, 2026 |
| May 19, 2026 | Bohjalian Thomas N | Director | award | 6,683 | $20.20 | $135K | 92,203 | May 20, 2026 |
| May 19, 2026 | Henry David | Director | award | 6,683 | $20.20 | $135K | 15,701 | May 20, 2026 |
| May 19, 2026 | Moore Constance B | Director | award | 6,683 | $20.20 | $135K | 91,221 | May 20, 2026 |
| May 19, 2026 | Rufrano Glenn J | Director | award | 6,683 | $20.20 | $135K | 25,701 | May 20, 2026 |
| May 19, 2026 | Wood Donald C | Director | award | 6,683 | $20.20 | $135K | 21,601 | May 20, 2026 |
| Apr 14, 2026 | Scott Peter A | President and CEO | tax withholding | 36,029 | $17.84 | $643K | 556,422 | Apr 15, 2026 |
| Mar 6, 2026 | Bohjalian Thomas N | Director | open-market buy | 10,000 | $18.09 | $181K | 85,520 | Mar 6, 2026 |
| Mar 4, 2026 | Gabbay Daniel | EVP, Chief Financial Officer | open-market buyindirect | 10 | $18.74 | $187 | 10 | Mar 5, 2026 |
| Feb 13, 2026 | Crowley Ryan E. | EVP and CIO | tax withholding | 736 | $17.96 | $13K | 198,504 | Feb 17, 2026 |
| Feb 10, 2026 | Crowley Ryan E. | EVP and CIO | tax withholding | 2,905 | $17.36 | $50K | 199,240 | Feb 11, 2026 |
| Feb 10, 2026 | Loope Andrew Edward | EVP, General Counsel | tax withholding | 3,650 | $17.36 | $63K | 184,486 | Feb 11, 2026 |
| Feb 10, 2026 | Callaway Amanda L | SVP & Chief Accounting Officer | tax withholding | 1,623 | $17.36 | $28K | 135,721 | Feb 11, 2026 |
| Feb 10, 2026 | Hull Robert E | EVP and COO | tax withholding | 4,097 | $17.36 | $71K | 297,338 | Feb 11, 2026 |
| Feb 10, 2026 | Scott Peter A | President and CEO | tax withholding | 10,820 | $17.36 | $188K | 592,451 | Feb 11, 2026 |
| Feb 9, 2026 | Gabbay Daniel | EVP, Chief Financial Officer | award | 32,107 | $17.13 | $550K | 191,158 | Feb 25, 2026 |
| Feb 9, 2026 | Crowley Ryan E. | EVP and CIO | award | 32,788 | $17.13 | $562K | 203,113 | Feb 11, 2026 |
| Feb 9, 2026 | Crowley Ryan E. | EVP and CIO | tax withholding | 968 | $17.13 | $17K | 202,145 | Feb 11, 2026 |
| Feb 9, 2026 | Loope Andrew Edward | EVP, General Counsel | tax withholding | 2,924 | $17.13 | $50K | 188,136 | Feb 11, 2026 |
| Feb 9, 2026 | Loope Andrew Edward | EVP, General Counsel | award | 32,588 | $17.13 | $558K | 191,060 | Feb 11, 2026 |
| Feb 9, 2026 | Callaway Amanda L | SVP & Chief Accounting Officer | award | 34,689 | $17.13 | $594K | 140,113 | Feb 11, 2026 |
| Feb 9, 2026 | Callaway Amanda L | SVP & Chief Accounting Officer | tax withholding | 2,769 | $17.13 | $47K | 137,344 | Feb 11, 2026 |
| Feb 9, 2026 | Hull Robert E | EVP and COO | tax withholding | 5,915 | $17.13 | $101K | 301,435 | Feb 11, 2026 |
| Feb 9, 2026 | Hull Robert E | EVP and COO | award | 33,859 | $17.13 | $580K | 307,350 | Feb 11, 2026 |
Full insider history for Healthcare Realty Trust Incorporated, or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held HR in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded HR by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Renaissance Technologies | Peter Brown | Q3 2026 | $52M | 3M | 0.07% | added +14.6% |
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- HEALTHCARE REALTY TRUST INCORPORATED, CIK 1360604 on EDGAR
- Extract generated
- November 16, 2026
- Withheld
- 5 line-years whose four quarters do not sum to the filed year: other income FY2011, depreciation amortization FY2012, other income FY2012, depreciation amortization FY2021, depreciation amortization FY2025
- Repaired
- 1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: net income FY2022
XBRL concepts behind each line
Income statement
RevenuesGeneralAndAdministrativeExpenseOperatingIncomeLossNonoperatingIncomeExpense, OtherNonoperatingIncomeExpenseNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsLongTermDebtLongTermDebt, combinedLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquireProductiveAssetsDepreciationAndAmortization, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated November 16, 2026.
- JSON file
/data/financials/HR.json